Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 3 subunit E pseudogene 4 (EIF3EP4) is classified as a pseudogene, meaning it is a non-functional copy of the EIF3E gene within the human genome[1][3]. While EIF3E is a protein-coding gene and a critical component of the eIF3 complex necessary for protein synthesis initiation and regulation of cell growth, differentiation, and apoptosis[3][6], EIF3EP4 does not produce a functional protein[1]. Pseudogenes may have regulatory functions in gene expression by acting as decoys for microRNAs or through RNA-mediated regulatory mechanisms[4][7], but there is no direct evidence that EIF3EP4 is a therapeutic target or is involved in drug interactions, disease mechanisms, or biomarkers. There is no indication of safety concerns or therapeutic relevance for EIF3EP4 based on current knowledge[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit E pseudogene 4 (EIF3EP4).